(Q44654883)

English

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

sociodemography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A A Nierenberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

D Mischoulon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Yeung

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J F Rosenbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

M Fava

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Acta Psychiatrica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

108

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

432-438

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

The course, morbidity, and costs of depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Outcome definitions and predictors in depression.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Predicting outcome of lithium added to antidepressants in resistant depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Gender differences in treatment response to sertraline versus imipramine in chronic depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Major depressive subtypes and treatment response.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Factors associated with 1-year outcome of major depression in the community.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Strengthening clinical effectiveness trials: equipoise-stratified randomization.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Variability of response to lithium augmentation in refractory depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Adding lithium to antidepressant therapy: factors related to therapeutic potentiation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00168.X

21 January 2018

Identifiers

10.1046/J.0001-690X.2003.00168.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14616224%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44654883&oldid=2037636617"